More than 100 civil society organisations, including Madhyam, have sought a major overhaul of the World Bank’s governing structures and policies following the scandal that led to the scrapping of its flagship publication, the ‘Doing Business’ report. This report ranks 190 countries on the Ease of Doing Business index. Following is the full text of the statement issued by CSOs on October 12, 2021:
In September, the World Bank announced that it would discontinue the publication of the Doing Business…
Even though the second wave of the COVID-19 pandemic has partially subsided across India, the extent to which citizens of the country have been affected continues to remain unclear. Official statistics show that the total number of those infected since the outbreak of the pandemic is pushing towards the 2.5 crore mark and more than 3 lakhs have lost their lives, figures that several prominent experts have questioned.
Well beyond these cold statistics is the cruel reality of human suffering…
The European Union (EU) is keen to enter into a trade agreement with India. EU was formed in 1993, and India was amongst the first countries to establish ties with this political and economic group. A cooperation agreement was signed between them in 1994. A decade later, in 2004, the relationship was upgraded to a ‘Strategic Partnership.’ The 2005 Joint Action Plan that followed committed both sides to develop trade and investment. Ever since then, both sides have been…
On March 1, Ngozi Okonjo-Iweala took over as Director-General of the World Trade Organization. She is the first woman and the first African to serve as the Director-General of the WTO. These are indeed remarkable achievements that need to be noticed and celebrated. As she holds dual Nigerian and US citizenship, Okonjo-Iweala is also the first American to hold this position.
For over two decades, India has acquired the reputation of being the ‘pharmacy of the world’ as its strong generic pharmaceutical industry has supplied affordable medicines to the global markets. Exports of medicines from India, which were around a billion dollars at the turn of the century, had increased to over $20 billion in 2019-20.
Indian companies had made critical interventions during the HIV/AIDS pandemic by supplying affordable antiretroviral medicines to African countries when the major pharmaceutical producers had demanded…
The view expressed in this blog are those of the authors and do not necessarily reflect the views of Madhyam. Madhyam welcomes and values your contributions to this blog. For further details, please contact us (madhyamblog@gmail.com).
We encourage you to communicate freely and openly about the themes covered in the blog.
You agree not to post any material that you do not have the right to post, for example, under intellectual property, confidentiality, privacy or other applicable laws.
You agree that your posted contributions will be licensed under the Creative Commons license applicable to comments where you post your material.
All comments will be moderated and published at the sole discretion of the Madhyam editorial team.
Madhyam reserves the right to delete, modify, refuse to post or remove (without notice or explanation) any Content, in whole or part, and to block any Contributor for any reason, at its sole discretion.
Madhyam also reserves the right to take any other action as may be appropriate in the circumstances.
